Genomic diagnostics company. Could be part of the genomic revolution.
Not so cheap anymore, high risk high reward
Not so cheap anymore, high risk high reward
註釋
earnings tomorrow after close,looking to buy breakout 8.50 or support channel trendline
註釋
add more on breakout註釋
Long sideways period but still holding and accumulated more of this stock. Adjusted channel.Some news: "Veracyte Chairman and CEO Bonnie Anderson Receives Prestigious Innovation Award at Biomedical Engineering Society Annual Meeting- The Coulter Foundation’s Wallace H. Coulter Award for Healthcare Innovation Recognizes Excellence and Leadership in Clinical Diagnostic Medicine"
businesswire.com/news/home/20171013005391/en/
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。